- Researchers find microneedle biosensors can be used to monitor the changing concentration of antibiotics in a patient’s system. - Findings published in The Lancet Digital Health, show the sensors enable real-time monitoring of changes in antibiotic concentration in the body, with similar results to those obtained from blood tests. Small, non-invasive patches worn on the skin can accurately detect the levels of medication in a patient's system, matching the accuracy of current
Read More
insulin
Actiste’s Unified IoT Diabetes Care Device Awarded CE Mark
- Actiste, the world’s first unified diabetes care device with eSIM technology for monitoring and treating insulin-dependent diabetes, has received two CE marks. - The EC certifications allow the company to move forward with its ongoing market entry and sales activities in the company's primary target markets in the Middle East and Southeast Asia and opens up for future sales in over 30 European countries, where Sweden is most imminent. - The development of the Actiste device was
Read More
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Novo Nordisk Integrates Smart Insulin Pens With Medtronic Continuous Glucose Monitoring (CGM) Devices
- Medtronic and Novo Nordisk to develop solutions enabling dosing data from Novo Nordisk Smart Insulin Pens to be shared with Medtronic continuous glucose monitoring devices. - Non-exclusive integration collaboration reflects both companies′commitment to making diabetes management easier by integrating key health technologies. - Novo Nordisk expects to launch its durable smart insulin pens, NovoPen® 6 and NovoPen Echo® Plus, as well as its disposable, pre-filled injection solution starting in
Read More
FDA Recalls Medtronic MiniMed Insulin Pumps for Potential Cybersecurity Risks
The U.S. Food and Drug Administration (FDA) is recalling certain Medtronic MiniMed insulin pumps due to potential cybersecurity risks and recommends that patients using these models switch their insulin pump to models that are better equipped to protect against these potential risks. To date, the FDA is not aware of any confirmed reports of patient harm related to these potential cybersecurity risks.Medtronic's MiniMed Insulin PumpsThe FDA is concerned that, due to cybersecurity vulnerabilities
Read More
Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores
One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.One Drop Blood Glucose MonitorOne Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then
Read More
Research: Livongo for Diabetes Program Improved Diabetes Distress Levels
Livongo, an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study conducted in collaboration with Eli Lilly and Company that demonstrated 94 percent of Livongo program Members who participated in a program survey achieved improved Diabetes Empowerment Scale-Short Form (DES-SF) or Diabetes Distress Scale 2 (DDS2) in year one. The research findings were presented on June 8, 2019, at the American Diabetes
Read More
Companion Medical Integrates Smart Insulin Pen with Rimidi Diabetes Management App
Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More
Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen
Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.
Impact of Integration
The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More
